Phillip Frost

Phillip Frost (#1801)

I was interested in a specialty that would permit me the time to reflect...I knew that surgery could never be for me because you're tied up in operating rooms most of the time. And I needed the freedom to do things.

$ 2 B
Pharmaceuticals
United States
M
89 Years

About Me

A long-time health care investor, inventor and founder, Phillip Frost now runs diagnostics-maker Opko Health. Frost joined Key Pharmaceuticals in 1972, reformulated its asthma drug and sold the company in 1986 for $836 million. Frost founded Ivax, a generic drugmaker, in 1987. He sold it to Teva Pharmaceuticals for $7.6 billion in 2005. In 2018, the SEC accused him of participating in a "pump-and-dump" scheme that generated over $27 million from unlawful stock sales. Frost denied the allegations in a personal statement. He settled with the SEC in 2018 without admitting or denying the allegations.

Achievements

Career Highlights

A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Phillip Frost’s rise and global influence.

#1834 Billionaires (2026)
#339 Forbes 400 (2020)

Wealth Growth

Net Worth Growth Over Time

Tracking Phillip Frost’s net worth journey over the years, highlighting key growth phases and financial milestones.

Current Net Worth: $2.3B (May 4, 2026)